Summary
Although a number of reports have now described an association between polymorphism of the LMP2 gene and disease phenotype in HLA-B27 positive individuals with ankylosing spondylitis (AS), some describe associations with acute anterior uveitis, others with juvenile onset disease, and one report provides no association. A recent study describes yet a further association with disease severity in patients with juvenile rheumatoid arthritis. We therefore hypothesized that the discrepant findings in adult disease may be a reflection of an underlying association with disease severity. Our study population consisted of 100 HLA-B27 positive Caucasians with AS of ten or more years duration. Clinical assessment of disease severity was based on a metrology index scoring five measurements, the modified health assessment questionnaire for the spondyloarthropathies, and a disease activity index consisting of a visual analog scale to score the amount of pain, stiffness and fatigue. LMP2 genotypes were assigned following polymerase chain reaction amplification from genomic DNA and restriction enzyme digestion with CfoI. Despite confirmation of a significantly higher prevalence of the LMP2 BB genotype in AAU positive (66.0%) versus AAU negative (45.2%) patients (P<0.05), we observed no association between LMP2 genotypes and any of the indices of disease severity. Furthermore, although a significant association was noted between the presence of peripheral synovitis and the functional index score (P<0.05), a history of AAU was not associated with more severe disease. Our data is thus internally consistent in demonstrating no association between LMP2 genotypes and either disease severity or peripheral arthritis, and supports the notion that polymorphism of LMP2 primarily influences the development of AAU and not some other phenotype of AS.
Similar content being viewed by others
References
Hammer RE, Maika SD, Richardson JA,et al. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human B2M: an animal model of HLA-B27-associated human disorders. Cell 1990; 63: 1099–1108.
Calin A, Marder A, Becks E, Burns T. Genetic differences between B27 positive patients with ankylosing spondylitis and B27 positive healthy controls. Arthritis Rheum 1983; 26: 1460–4.
Woodrow JC. Genetics of the spondarthropathies. In: Grennan, D.M., editor, Genetics of Rheumatic Diseases. Bailliere's Clin Rheumatol 1988; 2: 603–22.
Goldberg AL, Rock KL. Proteolysis, proteasomes and antigen presentation. Nature 1992; 357: 375–9.
Glynne R, Powis SH, Beck S, Kelly A, Kerr L, Trowsdale J. A proteasome-related gene between the two ABC transporter loci in the class II region of the human MHC. Nature 1991; 353: 357–60.
Kelly A, Powis SH, Glynne R, Radley E, Beck S, Trowsdale J. Second proteasome-related gene in the human MHC class II region. Nature 1991; 353: 667–8.
Maksymowych WP, Wessler A, Schmitt-Egenolf M,et al. Polymorphism in an HLA-linked proteasome gene influences phenotypic expression of disease in HLA-B27 individuals. J Rheumatol 1994; 21: 665–9.
Ploski R, Forre O, Flato B,et al. Association to HLA-DRB1 *08, HLA-DPB1 *03 and homozygosity for an HLA-linked proteasome gene in juvenile ankylosing spondylitis. Human Immunol 1995; 44: 88–96.
Maksymowych WP, Luong M, Wong C,et al. The LMP2A allele is associated with susceptibility to acute anterior uveitis in HLA-B27 positive juvenile and adult Mexican individuals with ankylosing spondylitis. Ann Rheum Dis (in press).
Burney RO, Pile KD, Gibson K,et al. Analysis of the MHC class II encoded components of the HLA class I antigen processing pathway in ankylosing spondylitis. Ann Rheum Dis 1994; 53: 58–60.
Pryhuber, K.G., Murray, K.J., Donnelly, P.,et al. Polymorphism in the LMP2 gene influences disease susceptibility and severity in HLA-B27 associated juvenile rheumatoid arthritis. J Rheumatol 1996; 23: 747–52.
Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: The Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994; 21: 2286–91.
Calin A, Garrett S, Whitelock H,et al. A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 1994; 21: 2281–5.
Abbott CA, Helliwell PS, Chamberlain MA. Functional assessment in ankylosing spondylitis: evaluation of a new self-administered questionnaire and correlation with anthropometric variables. Brit J Rheumatol 1994; 33: 1060–6.
Dougados M, Gueguen A, Nakache JP, Nguyen M, Mery C, Amor B. Evaluation of a functional index and an articular index in ankylosing spondylitis. J Rheumatol 1988; 15: 302–7.
Creemers MCW, Van 'T Mof MA, Franssen MJAM, Van De Putte LBA, Gribnau FWJ, Van Riel PLCM. A Dutch version of the functional index for ankylosing spondylitis: development and validation in a long-term study. Brit J Rheumatol 1994; 33: 842–6.
Daltroy LM, Larson MG, Roberts WN, Liang MH. A modification of the Health Assessment Questionnaire for the Spondyloarthropathies. J Rheumatol 1990; 17: 946–50.
van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum 1984; 27: 361–8.
Maksymowych WP, Suarez-Almazor M, Chou C-T, Russell AS. Polymorphism in the LMP2 gene influences susceptibility to extraspinal traspinal disease in HLA-B27 positive individuals with ankylosing spondylitis. Ann Rheum Dis 1995; 54: 321–4.
Macrae IF, Wright V. Measurement of back movement. Ann Rheum Dis 1965; 28: 584–9.
Moll JMH, Wright V. An objective clinical study of chest expansion. Ann Rheum Dis 1972; 31: 1–8.
Gustincich S, Manfioletti G, Del Sal G, Schneider C. A fast method for high-quality genomic DNA extraction from whole human blood. Biotechniques 1991; 11: 298–302.
Amor B, Santos RS, Nahal R, Listrat V, Dougados M. Predictive factors for long term outcome of spondyloarthropathies. J Rheumatol 1994; 21: 1883–9.
Pile KD, Laurent MR, Clare E, et al. Clinical assessment of AS. A study of observer variation in spinal measurements. Brit J Rheumatol 1991; 30: 29–34.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Maksymowych, W.P., Adlam, N., Lind, D. et al. Polymorphism of the LMP2 gene and disease phenotype in ankylosing spondylitis: No association with disease severity. Clin Rheumatol 16, 461–465 (1997). https://doi.org/10.1007/BF02238938
Issue Date:
DOI: https://doi.org/10.1007/BF02238938